Home › Research › Tau biomarkers
CSF biomarkers in different phenotypes of Parkinson disease
Jellinger KA.. Journal of neural transmission (Vienna, Austria : 1996), 2011-11-08
Topic: Brain proteins, microglia and lab models
Plain-language summary
CSF biomarker studies were performed in 6 patients each with tremor-dominant (TD) and non-tremor-dominant (NT) Parkinson disease (PD) patients, 27 Alzheimer disease (AD) and 17 age-matched controls. In both NT-PD and AD patients total tau levels and the cortex tau/Aβ-42 were significantly increased compared to both TD-PD patients and controls (p < 0.01). These data in a small cohort confirm previous studies, corroborating the opinion that CSF levels of tau protein and the index total-tau/Aβ-42 may be potential markers of the severity of neurodegeneration in PD.
What this study adds
Evidence grade: Moderate
In a small group of patients, this study found that total tau levels and the ratio of tau to amyloid-42 in spinal fluid were higher in people with non-tremor-dominant Parkinson's disease and Alzheimer's disease than in those with tremor-dominant Parkinson's disease or controls. The authors suggest these markers may reflect the severity of nerve cell loss, but the study is small and does not test a treatment.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jellinger, K. A. (2012). CSF biomarkers in different phenotypes of Parkinson disease. Journal of neural transmission (Vienna, Austria : 1996). https://doi.org/10.1007/s00702-011-0736-0
Vancouver
Jellinger KA. CSF biomarkers in different phenotypes of Parkinson disease. Journal of neural transmission (Vienna, Austria : 1996). 2012. doi:10.1007/s00702-011-0736-0. PMID: 22065209.
BibTeX
@article{jellinger2012-22065209,
author = {Jellinger, K. A.},
title = {{CSF biomarkers in different phenotypes of Parkinson disease}},
journal = {Journal of neural transmission (Vienna, Austria : 1996)},
year = {2012},
doi = {10.1007/s00702-011-0736-0},
pmid = {22065209},
url = {https://doi.org/10.1007/s00702-011-0736-0}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- In both NT-PD and AD patients total tau levels and the cortex tau/Aβ-42 were significantly increased compared to both TD-PD patients and controls (p < 0.01).
- These data in a small cohort confirm previous studies, corroborating the opinion that CSF levels of tau protein and the index total-tau/Aβ-42 may be potential markers of the severity of neurodegeneration in PD.
Why it matters
In a small group of patients, this study found that total tau levels and the ratio of tau to amyloid-42 in spinal fluid were higher in people with non-tremor-dominant Parkinson's disease and Alzheimer's disease than in those with tremor-dominant Parkinson's disease or controls. The authors suggest these markers may reflect the severity of nerve cell loss, but the study is small and does not test a treatment.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthModerate
How this study scored 36/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 35 of the 97 points we could judge it on, which is 36 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of neural transmission (Vienna, Austria : 1996)) |
| Journal's citation record | 2 / 4 | Journal of Neural Transmission: journal h-index 167 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2012 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 17 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.1 citations a year over 16 year(s) since 2012 |
| Impact for its field and year | 2 / 6 | Cited 1.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author K. A. Jellinger: h-index 137 (OpenAlex, whole career) |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 22065209) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 35 / 97 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 35 of the 97 points we could judge it on is 36 out of 100. |
| Total | 36 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.